Abstract
Antibody-based therapy depletes myeloid-biased hematopoietic stem cells (my-HSCs) to rejuvenate the immune system and improve immune responses in aged mice.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aging* / immunology
-
Animals
-
Hematopoietic Stem Cell Transplantation
-
Hematopoietic Stem Cells* / immunology
-
Humans
-
Mice